Market Place
Sourcing Support
All News #Library
Biotech
Halozyme & Skye Sign Global ENHANZE Nimacimab Co-Formulated Deal
05 Jan 2026 //
PR NEWSWIRE
Bench International Appoints Jim Lang To Halozyme Therapeutics
17 Dec 2025 //
PR NEWSWIRE
Halozyme Wins German Injunction Blocking Keytruda Distribution
08 Dec 2025 //
INDPHARMAPOST
Halozyme Acquires Elektrofi, Enhancing Drug Delivery Portfolio
18 Nov 2025 //
PR NEWSWIRE
Merus, Halozyme Sign Global Pact to Develop Petosemtamab
17 Nov 2025 //
PR NEWSWIRE
Halozyme Therapeutics Added to Russell 1000® Index
30 Jun 2025 //
PR NEWSWIRE
Halozyme: Argen-X gets CHMP nod for Vygart in CIDP with enhanze
28 Apr 2025 //
PR NEWSWIRE
Halozyme sues Merck over subcutaneous Keytruda
25 Apr 2025 //
PRESS RELEASE
EU Commission OKs DARZALEX-based Regimen for New Myeloma
09 Apr 2025 //
PR NEWSWIRE
EU Commission OKs Rybrevant with Enhanze for EGFR Lung Cancer
07 Apr 2025 //
PR NEWSWIRE
Merck’s Injectable Keytruda Create Legal Dispute With Halozyme
06 Mar 2025 //
BIOSPACE
Halozyme Update On Licensee Co-Formulation Patent Hearing
24 Oct 2024 //
PR NEWSWIRE
FDA Approves Roche`s Subcutaneous OCREVUS ZUNOVO With ENHANZE
13 Sep 2024 //
PR NEWSWIRE
Halozyme Announces Approval of Roche`s Tecentriq® SC with ENHANZE
29 Aug 2023 //
PR NEWSWIRE
Roche scores with subcutaneous version of MS drug Ocrevus
14 Jul 2023 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.